These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
281 related articles for article (PubMed ID: 36262171)
1. Untangling Amyloidosis: Recent Advances in Cardiac Amyloidosis. Kim D; Choi JO; Kim K; Kim SJ; Jeon ES Int J Heart Fail; 2020 Oct; 2(4):231-239. PubMed ID: 36262171 [TBL] [Abstract][Full Text] [Related]
2. Cardiac Amyloidosis: Overlooked, Underappreciated, and Treatable. Rubin J; Maurer MS Annu Rev Med; 2020 Jan; 71():203-219. PubMed ID: 31986086 [TBL] [Abstract][Full Text] [Related]
3. Advances in the treatment of transthyretin cardiac amyloidosis: Current and emerging therapies. Warner AL Pharmacotherapy; 2021 Dec; 41(12):1081-1091. PubMed ID: 34669976 [TBL] [Abstract][Full Text] [Related]
5. Transthyretin cardiac amyloidosis: an update on diagnosis and treatment. Yamamoto H; Yokochi T ESC Heart Fail; 2019 Dec; 6(6):1128-1139. PubMed ID: 31553132 [TBL] [Abstract][Full Text] [Related]
6. Transthyretin Cardiac Amyloidosis: An Evolution in Diagnosis and Management of an "Old" Disease. Smiley DA; Rodriguez CM; Maurer MS Cardiol Clin; 2022 Nov; 40(4):541-558. PubMed ID: 36210137 [TBL] [Abstract][Full Text] [Related]
7. Diagnostic value of cardiovascular magnetic resonance in comparison to endomyocardial biopsy in cardiac amyloidosis: a multi-centre study. Chatzantonis G; Bietenbeck M; Elsanhoury A; Tschöpe C; Pieske B; Tauscher G; Vietheer J; Shomanova Z; Mahrholdt H; Rolf A; Kelle S; Yilmaz A Clin Res Cardiol; 2021 Apr; 110(4):555-568. PubMed ID: 33170349 [TBL] [Abstract][Full Text] [Related]
8. [Heart damage in the combined types of systemic amyloidosis]. Rybakova MG; Vlasova MT; Kuznetsova IA; Krylova YS Arkh Patol; 2021; 83(5):21-26. PubMed ID: 34609800 [TBL] [Abstract][Full Text] [Related]
9. Recent advances in the diagnosis and management of amyloid cardiomyopathy. Nijst P; Tang WW Fac Rev; 2021; 10():31. PubMed ID: 33817700 [TBL] [Abstract][Full Text] [Related]
10. Nuclear Imaging for Cardiac Amyloidosis: Bone Scan, SPECT/CT, and Amyloid-Targeting PET. Paeng JC; Choi JY Nucl Med Mol Imaging; 2021 Apr; 55(2):61-70. PubMed ID: 33968272 [TBL] [Abstract][Full Text] [Related]
11. Heart of the Matter: Decoding the Underdiagnosed Cardiac Amyloidosis. Kaiser ME; Lewis TJ Cureus; 2023 Dec; 15(12):e50527. PubMed ID: 38098740 [TBL] [Abstract][Full Text] [Related]
12. Trends in diagnosis, referral, red flag onset, patient profiles and natural outcome of de novo cardiac amyloidosis and their multidisciplinary implications. Debonnaire P; Claeys M; De Smet M; Trenson S; Lycke M; Demeester C; Van Droogenbroeck J; De Vriese AS; Verhoeven K; Vantomme N; Van Meirhaeghe J; Willandt B; Lambert M; de Paepe P; Delanote J; De Geeter F; Tavernier R Acta Cardiol; 2022 Nov; 77(9):791-804. PubMed ID: 34565298 [TBL] [Abstract][Full Text] [Related]
13. Amyloid transthyretin cardiac amyloidosis: diagnosis and management. Di Giovanni B; Gustafson D; Delgado DH Expert Rev Cardiovasc Ther; 2019 Sep; 17(9):673-681. PubMed ID: 31478389 [No Abstract] [Full Text] [Related]
14. The importance of pathways to facilitate early diagnosis and treatment of patients with cardiac amyloidosis. Kwok CS; Moody WE Ther Adv Cardiovasc Dis; 2023; 17():17539447231216318. PubMed ID: 38099406 [TBL] [Abstract][Full Text] [Related]